본문 바로가기
KERD
논문KCI 등재

Vibrio vulnificus infection: a persistent threat to public health

Dong-Min Kim|Na Ra Yun
대한내과학회 (The Korean Association Of Internal Medicine)|2018.11|The Korean Journal of Internal Medicine|제33권 제6호|pp. 1070-1078|DOI https://doi.org/10.3904/kjim.2018.159

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

DiagnosisPrognosisTherapeuticsVibrio vulnificus
주제분류내과학

초록

Vibrio vulnificus is a gram-negative bacterium that can cause serious, potentially fatal infections. V. vulnificus causes three distinct syndromes: an overwhelming primary septicemia caused by consuming contaminated seafood, wound infections acquired when an open wound is exposed to contaminated warm seawater, and gastrointestinal tract-limited infections. Case-fatality rates are higher than 50% for primary septicemia, and death typically occurs within 72 hours of hospitalization. Risk factors for V. vulnificus infection include chronic liver disease, alcoholism, and hematological disorders. When V. vulnificus infection is suspected, appropriate antibiotic treatment and surgical interventions should be performed immediately. Third-generation cephalosporin with doxycycline, or quinolone with or without third-generation cephalosporin, may be potential treatment options for patients with V. vulnificus infection.

Abstract

Vibrio vulnificus is a gram-negative bacterium that can cause serious, potentially fatal infections. V. vulnificus causes three distinct syndromes: an overwhelming primary septicemia caused by consuming contaminated seafood, wound infections acquired when an open wound is exposed to contaminated warm seawater, and gastrointestinal tract-limited infections. Case-fatality rates are higher than 50% for primary septicemia, and death typically occurs within 72 hours of hospitalization. Risk factors for V. vulnificus infection include chronic liver disease, alcoholism, and hematological disorders. When V. vulnificus infection is suspected, appropriate antibiotic treatment and surgical interventions should be performed immediately. Third-generation cephalosporin with doxycycline, or quinolone with or without third-generation cephalosporin, may be potential treatment options for patients with V. vulnificus infection.

참고문헌 (48)

  1. "Summary of human Vibrio isolates reported to CDC, 2004" (2004)[URL]
  2. Bross MH, "Vibrio vulnificus infection: diagnosis and treatment", Am Fam Physician, 76, pp.539~544 (2007)
  3. Centers for Disease Control and Prevention (CDC), "Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food: 10States, United States, 2005", MMWR Morb Mortal Wkly Rep, 55, pp.392~395 (2005)
  4. Hsueh PR, "Vibrio vulnificus in Taiwan", Emerg Infect Dis, 10, pp.1363~1368 (2004)
  5. Daniels NA, "Vibrio vulnificus oysters: pearls and perils", Clin Infect Dis, 52, pp.788~792 (2011)
  6. Johnston JM, "Vibrio vulnificus. Man and the sea", JAMA, 253, pp.2850~2853 (1985)
  7. Barton JC, "Hemochromatosis and Vibrio vulnificus wound infections", J Clin Gastroenterol, 43, pp.890~893 (2009)
  8. Haq SM, "Chronic liver disease and consumption of raw oysters: a potentially lethal combination: a review of Vibrio vulnificus septicemia", Am J Gastroenterol, 100, pp.1195~1199 (2005)
  9. 박석돈, "Vibrio vulnificus 패혈증의 임상적 연구", 대한피부과학회지, 44(6), pp.696~707 (2006), 대한피부과학회
  10. Wright AC, "Role of iron in the pathogenesis of Vibrio vulnificus infections", Infect Immun, 34, pp.503~507 (1981)
  11. Lesic B, "Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica", Antimicrob Agents Chemother, 46, pp.1741~1745 (2002)
  12. Neupane GP, "Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus", Transfusion, 49, pp.1762~1769 (2009)
  13. Lee SH, "Retrospective analysis of epidemiological aspects of Vibrio vulnificus infections in Korea in 2001-2010", Jpn J Infect Dis, 66, pp.331~333 (2013)
  14. Shin YH, "National surveillance of Vibrio vulnificus infections in 1998", Korean J Infect Dis, 31, pp.232~236 (1999)
  15. Merkel SM, "Essential role for estrogen in protection against Vibrio vulnificus-induced endotoxic shock", Infect Immun, 69, pp.6119~6122 (2001)
  16. 김동민, "비브리오 패혈증", 대한내과학회지, 82(6), pp.671~679 (2012), 대한내과학회[DOI]
  17. Chuang YC, "Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment", Clin Infect Dis, 15, pp.271~276 (1992)
  18. Yun NR, "pH level as a marker for predicting death among patients with Vibrio vulnificus infection, South Korea, 2000-2011", Emerg Infect Dis, 21, pp.259~264 (2015)
  19. 옥혜성, "패혈증 비브리오균에 의한 위장관염에 이은 급성 화농성 척추염 1예", 대한내과학회지, 86(4), pp.519~522 (2014), 대한내과학회[DOI]
  20. Kim CS, "septicemia, necrotizing fasciitis, and peritonitis due to Vibrio vulnificus in a patient undergoing continuous ambulatory peritoneal dialysis: a case report", BMC Infect Dis, 15, pp.422~ (2015)
  21. Shapiro RL, "The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. Vibrio Working Group", J Infect Dis, 178, pp.752~759 (1998)
  22. Klontz KC, "Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987", Ann Intern Med, 109, pp.318~323 (1988)
  23. Chen Y, "Vibrio vulnificus infection in patients with liver disease: report of five autopsy cases", Virchows Arch, 441, pp.88~92 (2002)
  24. Dechet AM, "Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006", Clin Infect Dis, 46, pp.970~976 (2008)
  25. Tacket CO, "Clinical features and an epidemiological study of Vibrio vulnificus infections", J Infect Dis, 149, pp.558~561 (1984)
  26. Ma KA, "Emergency debridement with empirical antibiotics treatment for clinically diagnosed Vibrio sepsis", Korean J Infect Dis, 29, pp.297~303 (1997)
  27. Lee JY, "Clinical usefulness of real-time polymerase chain reaction for the diagnosis of Vibrio vulnificus infection using skin and soft tissues", Am J Trop Med Hyg, 97, pp.443~446 (2017)
  28. Kim HS, "Comparison of conventional, nested, and real-time PCR assays for rapid and accurate detection of Vibrio vulnificus", J Clin Microbiol, 46, pp.2992~2998 (2008)
  29. Ryu HH, "Necrotizing soft tissue infection with gas formation caused by Vibrio vulnificus and misdiagnosed as Pseudomonas aeruginosa", Am J Emerg Med, 31, pp.464~ (2013)
  30. Halow KD, "Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention", J Am Coll Surg, 183, pp.329~334 (1996)
  31. Bilton BD, "Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study", Am Surg, 64, pp.397~400 (1998)
  32. McHenry CR, "Determinants of mortality for necrotizing soft-tissue infections", Ann Surg, 221, pp.558~563 (1995)
  33. Chao WN, "Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis", Am J Surg, 206, pp.32~39 (2013)
  34. Han F, "Antimicrobial susceptibilities of Vibrio parahaemolyticus and Vibrio vulnificus isolates from Louisiana Gulf and retail raw oysters", Appl Environ Microbiol, 73, pp.7096~7098 (2007)
  35. Bowdre JH, "Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline", J Pharmacol Exp Ther, 225, pp.595~598 (1983)
  36. Chuang YC, "In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus", Antimicrob Agents Chemother, 41, pp.2214~2217 (1997)
  37. Tang HJ, "In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus", Antimicrob Agents Chemother, 46, pp.3580~3584 (2002)
  38. Kim DM, "In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus", Antimicrob Agents Chemother, 49, pp.3489~3491 (2005)
  39. Jang HC, "In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis", PLoS One, 9, pp.e101118~ (2014)
  40. "Vibrio vulnificus: general information" (2018)[URL]
  41. Chen SC, "Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus:retrospective analysis of an 8 year period", J Antimicrob Chemother, 67, pp.488~493 (2012)
  42. Trinh SA, "Efficacy of ceftriaxone, cefepime, doxycycline, ciprofloxacin, and combination therapy for Vibrio vulnificus foodborne septicemia", Antimicrob Agents Chemother, 61, pp.e01106~e01117 (2017)
  43. Yu W, "Clinical features and treatment of patients with Vibrio vulnificus infection", Int J Infect Dis, 59, pp.1~6 (2017)
  44. Lin YS, "Tigecycline salvage therapy for necrotizing fasciitis caused by Vibrio vulnificus: case report in a child", J Microbiol Immunol Infect, 49, pp.138~141 (2016)
  45. Kuo Chou TN, "Predictors of mortality in skin and soft-tissue infections caused by Vibrio vulnificus", World J Surg, 34, pp.1669~1675 (2010)
  46. Chen SC, "Clinical outcomes and prognostic factors for patients with Vibrio vulnificus infections requiring intensive care: a 10-yr retrospective study", Crit Care Med, 38, pp.1984~1990 (2010)
  47. Kim DM, "Vibrio vulnificus DNA load and mortality", J Clin Microbiol, 49, pp.413~415 (2011)
  48. Lee JY, "Tumor necrosis factor-αand mortality in patients infected with Vibrio vulnificus", Am J Trop Med Hyg, 84, pp.426~428 (2011)

관련 논문AI추천

Isolation of Vibrio vulnificus from Seawater and Emerging Vibrio vulnificus Septicemia on Jeju Island김영리, 방익찬, 이근화, 허상택대한감염학회 · Infection and Chemotherapy2014 · 제46권 제2호Historical and Clinical Perspective of Vibrio vulnificus Infections in KoreaJung Sook In, Kang Seung-Ji, Peck Kyong Ran대한감염학회 · Infection and Chemotherapy2020 · 제52권 제2호A Fatal Case of Bacteremia Caused by Vibrio cholerae Non-O1/O139김수정, 장현하, Hwang Soyoon, Jung Hyejin, Kim Hye-In, Kim Shin-Woo, Kim Yoonjung, Lee Jong-Myung, Park Han-Ki대한감염학회 · Infection and Chemotherapy2021 · 제53권 제2호A Case of Skin and Soft Tissue InfectionCaused by Non-O1, Non-O139 Vibrio choleraein a Patient with Liver Cirrhosis강문원, 김상일, 김양리, 박연준, 엄재선, 오병선, 이승환대한감염학회 · Infection and Chemotherapy2005 · 제37권 제2호패혈증비브리오균에 의한 패혈증: 부검 증례김형석, 나주영, 박정우, 박종태, 안으리, 오연호, 허기영대한법의학회 · 대한법의학회지2015 · 제39권 제2호Septic Shock due to Vibrio alginolyticus in a Cirrhotic Patient: The First Case in Korea문수연, 양희영, 이동영, 이미숙, 이상오, 이희주연세대학교의과대학 · Yonsei Medical Journal2008 · 제49권 제2호

이 간행물의 다른 논문 (28건)

Palliative and end-of-life care for heart failure patients in an aging societyAkinori Sawamura, Toyoaki Murohara, Takahiro Okumurapp. 1039-1049Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancerDong-Jun Lim, 조관훈pp. 1050-1057Neuropathic cancer pain: prevalence, pathophysiology, and managementSo Young Yoon, Jeeyoung Ohpp. 1058-1069The importance of treating mild hyperglycemia in pregnant women with diabetesKyung-Soo Kimpp. 1079-1080Piggybacked by PEGylation?신기철pp. 1081-1083
원문 보기